Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient

ABSTRACT Visceral leishmaniasis (VL) is an opportunistic disease in immunosuppressed individuals, who may present severe clinical conditions, such as the ones described in this patient. She lived in an endemic region for VL, and was possibly infected with L. (L.) infantum chagasi through the bite of...

Full description

Bibliographic Details
Published in:Revista do Instituto de Medicina Tropical de São Paulo
Main Authors: Luciamáre Perinetti Alves Martins, Josianne Thomazini Fukasawa, Mirella Beni Balbino Ferreira Messias, Roberto Esteves Pires Castanho, Leticia Abrantes Andrade, Márcia Aparecida Sperança, Rodrigo Buzinaro Suzuki
Format: Article in Journal/Newspaper
Language:English
Published: Universidade de São Paulo (USP) 2022
Subjects:
Online Access:https://doi.org/10.1590/s1678-9946202264021
https://doaj.org/article/591b2bab4b2c47f7a47e74d21774d274
Description
Summary:ABSTRACT Visceral leishmaniasis (VL) is an opportunistic disease in immunosuppressed individuals, who may present severe clinical conditions, such as the ones described in this patient. She lived in an endemic region for VL, and was possibly infected with L. (L.) infantum chagasi through the bite of a contaminated sand fly. This initial infection has triggered a pemphigus vulgaris condition by immunogenic proteins present in the mosquito's saliva. The immunosuppression caused by the use of high doses of corticosteroids to control the disease promoted a severe VL condition, with hepatosplenomegaly, thrombocytopenia and hemorrhages, requiring hospitalization and the onset of a subsequent SARS-CoV-2 infection. Due to the intensity of clinical manifestations related to VL, aggravated by COVID-19, she died two days after admission to the Clinical Hospital of Marilia Medical School (HC–Famema).